| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.14 | 0.004 |